Acquisition by Karen Drexler of 1083 shares of ResMed subject to Rule 16b-3

RMD Stock   38.15  0.25  0.65%   
Slightly above 62% of Resmed's investor base is looking to short. The analysis of overall sentiment of trading Resmed Inc DRC stock suggests that many investors are alarmed at this time. Resmed's investing sentiment can be driven by a variety of factors including economic data, Resmed's earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by ResMed Inc Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
ResMed insider trading alert for acquisition of resmed common stock by Karen Drexler, Director, on 22nd of November 2024. This event was filed by ResMed Inc with SEC on 2024-11-20. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Resmed's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Resmed's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Resmed Fundamental Analysis

We analyze Resmed's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Resmed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Resmed based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Total Debt

Total Debt Comparative Analysis

Resmed is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Resmed Inc DRC Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Resmed stock to make a market-neutral strategy. Peer analysis of Resmed could also be used in its relative valuation, which is a method of valuing Resmed by comparing valuation metrics with similar companies.

Additional Tools for Resmed Stock Analysis

When running Resmed's price analysis, check to measure Resmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Resmed is operating at the current time. Most of Resmed's value examination focuses on studying past and present price action to predict the probability of Resmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Resmed's price. Additionally, you may evaluate how the addition of Resmed to your portfolios can decrease your overall portfolio volatility.